Welcome to our dedicated page for 3M SEC filings (Ticker: MMM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
3M Company filings document operating results, guidance, governance, capital structure, and material corporate events for the company's diversified industrial and consumer portfolio. Form 8-K reports include quarterly earnings releases, financial-condition updates, board changes, and material agreements such as credit facilities and related guarantees.
Proxy filings describe director elections, board committee structure, executive compensation, shareholder voting matters, and governance policies. The filing record also identifies 3M's common stock and listed notes, alongside disclosures involving litigation-related adjustments, manufactured PFAS products, Solventum ownership effects, transformation costs, and other items affecting reported results and risk presentation.
3M executive Zoe L. Dickson reported equity compensation activity in 3M common stock. On February 2, 2026, she was credited with 11,964.32 shares at $0 per share under a performance share award granted on March 1, 2023, after performance goals were certified.
She previously elected to defer receipt of these shares and will not have voting or investment power over them until they are issued. On the same date, 282 shares were withheld at $0 to cover estimated taxes. After these transactions, she beneficially owns 17,859.4401 shares directly and 299 shares indirectly through a 401k/paesop trust.
3M executive Kevin H. Rhodes reported equity compensation activity tied to performance share awards. On February 2, 2026, he acquired 23,251.392 shares of 3M common stock at $0 per share when performance-based vesting requirements for awards granted on March 1, 2023 were certified as achieved.
On the same date, 4,732 shares were withheld, at $0, to cover taxes, leaving him with 33,738.3379 shares of 3M common stock held directly. Half of the vested shares were deferred, and he will not have voting or investment power over those deferred shares until they are issued.
3M Group President Beatriz Karina Chavez Rodriguez reported equity compensation activity in 3M common stock. On February 2, 2026, she acquired 8,650.304 shares at $0 under a performance share award granted on March 1, 2023, after performance goals were certified as achieved.
On the same date, 3,945 shares were withheld at $0 to cover estimated taxes related to this award. Following these transactions, she directly held 14,259.3048 shares of common stock, and a separate holding line reflects 2,209.385 shares, which includes dividend share equivalents accrued under 3M's Deferred Compensation Plan.
3M EVP & Chief Information Digital Officer Mark W. Murphy reported equity compensation activity in 3M common stock. On February 2, 2026, he acquired 11,173.408 shares at $0 per share from performance share awards granted on March 1, 2023, after performance goals were certified as met.
Murphy had previously elected to defer receipt of 93% of these performance shares and will not have voting or investment power over the deferred portion until they are issued. On the same date, 603 shares were withheld to cover taxes, also at $0 per share.
After these transactions, Murphy directly beneficially owned 17,214.9561 shares of 3M common stock, including shares acquired under 3M's General Employee Stock Purchase Plan.
3M Executive Vice President John P. Banovetz reported equity changes in his 3M common stock holdings. On February 2, 2026, he acquired 12,513.696 shares at $0 when a performance share award granted on March 1, 2023 vested after meeting performance-based requirements. On the same date, 4,859 shares were withheld, at $0, to cover estimated taxes. After these transactions, he directly owned 39,515.1246 shares of 3M common stock, including shares from the General Employee Stock Purchase Plan and dividend share equivalents accrued under 3M's Deferred Compensation Plan.
3M Company has filed a shelf registration that allows it to offer debt securities and common stock from time to time after the registration becomes effective. Future offerings may be made through underwriters, dealers, agents, or directly to investors, with specific terms set in prospectus supplements.
3M states that net proceeds from any sales will generally be used for corporate purposes and may be temporarily invested in marketable securities. The filing incorporates 3M’s latest annual report, proxy materials, and future Exchange Act reports by reference and directs investors to detailed risk factors in those documents.
3M Company filed its 10-K reporting 2025 net sales of $24,948 million, up 1.5%, with organic sales up 0.9%. GAAP operating margin was 18.6% and adjusted margin 23.4%, reflecting productivity gains but also higher PFAS-related litigation and transformation costs.
GAAP EPS was $6.00, down 17%, while adjusted EPS rose 10% to $8.06, helped by lower restructuring, growth investments and a gain on an investment. 3M completed its exit from PFAS manufacturing by year-end 2025, continues to manage substantial PFAS liabilities including the PWS Settlement of $10.5–$12.5 billion through 2036, and will contribute $6.0 billion under the Combat Arms Earplug settlement through 2029.
The company spun off its Health Care business as Solventum in 2024, now reported as discontinued operations, and is managing related dis-synergies and transition agreements. 3M maintained a global footprint with about 60,500 employees and repurchased 3.4 million shares in Q4 2025 under a $7.5 billion buyback authorization.
3M director James R. Fitterling reported a routine compensation deferral into stock equivalents. On January 23, 2026, an entity described as a corporation associated with him acquired 287.929 shares of 3M common stock equivalents at $160.63 per share, recorded as indirect ownership "By Corporation". According to the plan footnote, this non‑employee director elected to defer compensation into a common stock equivalents account under 3M’s Compensation Plan for Non‑Employee Directors and has no voting or investment powers over that account.
After this transaction, the corporation‑held indirect position is shown as 6,475.503 common stock equivalents. The filing also lists 11,412.005 shares of common stock held directly and 200 shares held indirectly By Spouse, which are reported holdings rather than new transactions.